Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.4Revenue $M0.8Net Margin (%)-12,279.7Altman Z-Score-14.7
Enterprise Value $M25.5EPS $-2.9Operating Margin %-12,282.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.7Pre-tax Margin (%)-12,297.0Higher ROA y-yY
Price/Book5.010-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales1255-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-92.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-157.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTXGeorge Soros 2014-09-30 Sold Out $4.325 - $5.64
($5.07)
$ 2.69-47%Sold Out0
ONTXGeorge Soros 2014-06-30 Buy $4.18 - $6.22
($5.24)
$ 2.69-49%New holding10,774
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy143,480$8.47-69.3 view
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy143,480$8.47-69.3 view
Kumar RameshPresident and CEO 2014-02-10Sell33,543$15.07-82.75 view
Kumar RameshPresident and CEO 2014-02-03Sell60,000$15.05-82.72 view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy57,295$11.92-78.19 view
Michael & Jane Hoffman 2013 De10% Owner 2014-01-27Buy57,295$11.92-78.19 view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-22Buy5,000$14.39-81.93 view
Hoffman Michael BDirector, 10% Owner 2013-11-22Buy5,000$14.39-81.93 view
Reddy E PremkumarDirector 2013-11-18Buy5,000$12.1-78.51 view
Hoffman Michael BDirector, 10% Owner 2013-11-18Buy5,000$11.87-78.1 view

Quarterly/Annual Reports about ONTX:

News about ONTX:

Articles On GuruFocus.com
Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

More From Other Websites
Onconova Therapeutics (ONTX) Shows Strength: Stock Up 9.7% - Tale of the Tape Jul 02 2015
Onconova Therapeutics, Inc. to Present Corporate Update at the Cantor Fitzgerald Healthcare... Jul 01 2015
Onconova Therapeutics, Inc. to Present Corporate Update at the Cantor Fitzgerald Healthcare... Jul 01 2015
Onconova Therapeutics upgraded by Piper Jaffray Jul 01 2015
Onconova to Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting on Tuesday, June 30 in... Jun 23 2015
Onconova to Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting on Tuesday, June 30 in... Jun 23 2015
ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 17 2015
Onconova Presents Patient Selection Criteria and Intermediate Clinical Endpoints for Rigosertib in... Jun 15 2015
Onconova Presents Patient Selection Criteria and Intermediate Clinical Endpoints for Rigosertib in... Jun 15 2015
Onconova Presents Clinical Data on Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at... Jun 01 2015
Onconova Presents Clinical Data on Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at... Jun 01 2015
ONCONOVA THERAPEUTICS, INC. Financials May 22 2015
Onconova Therapeutics (ONTX) Looks Good: Stock Up 5.8% - Tale of the Tape May 18 2015
Onconova Therapeutics (ONTX) Shares March Higher, Can It Continue? - Tale of the Tape May 18 2015
ONCONOVA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report May 15 2015
What's in Store for Autodesk (ADSK) in Q1 Earnings? - Analyst Blog May 15 2015
Why Onconova Therapeutics (ONTX) Might Surprise This Earnings Season - Tale of the Tape May 15 2015
Will Kite Pharma (KITE) Miss Earnings Estimates Yet Again? - Analyst Blog May 14 2015
Onconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2015 Financial... May 14 2015
ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 14 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK